Prospective study of safety and usefulness of transcatheter arterial chemo- embolization by miriplatin and lipiodol for thoracic malignant tumors
Phase 2
- Conditions
- Thoracic malignant tumors
- Registration Number
- JPRN-UMIN000024322
- Lead Sponsor
- Kameda Medical Center
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 30
Inclusion Criteria
Not provided
Exclusion Criteria
1. The patients without inclusion criteria. 2. The patients with allergy for blood vessel contrast medium. 3. The patients with renal failure. 4. The patients who are judged to be unsuitable by doctors.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method